Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 03-Nov-2017

12-lead ECG for Home Use


The Company core business is electrocardiogram (ECG) devices and services. With the wide acceptance of mobile and wearable technologies, the ECG industry is at a critical point of transformation. We have reinvented the ECG that will disrupt the current ECG market, and create new ECG markets. We are making hospital quality 12-lead ECG available to patients at home. Our vision is to become the “Leader in ECG Technology” that will dominate the new and emerging ECG markets.


Original YouTube URL: Open

Introduction Video

Additional Questions

Who is your customer?

QT ECG is the world's first hospital-quality 12-lead ECG for home use. Patients with chronic heart disease can get QT ECG from doctor's prescriptions.

What problem does this idea/product solve or what market need does it serve?

Heart disease is No. killer worldwide. 12-lead ECG is the most commonly used test for the heart. Patients can take care of their health problems much better if they have the tools they need. But, there is no 12-lead ECG for home use-- until now. Introducing the QT ECG!

What attributes will make this idea/product successful? Why do you believe that those features will create success?

Home use ECG market will exceed $10 B worldwide in the next 10 years. With the increasing demand for telemedicine and home care, and prevalence of mobile devices, Internet and cloud management, this is the perfect timing to bring 12-lead ECG to homes.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

We will launch QT ECG for home use in Q3 of 2018. Initial targets are patients who just had a heart attack, after CABG or stents, to detect possible second heart attack in the following 12 months. We have 3 issued patents and 6 pending patents, and superior algorithm and trade secrets.